The Role ofP53andMDM2Polymorphisms in the Risk of Esophageal Squamous Cell Carcinoma
Authors:
- 15 October 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (20) , 9582-9587
Abstract
The tumor suppressor P53 pathway plays a crucial role in preventing carcinogenesis and genetic variations of this pathway may be associated with cancer susceptibility. We tested this hypothesis by examining the contribution of functional polymorphisms in P53 and MDM2 to risk of esophageal squamous cell carcinoma (ESCC). DNA from 758 ESCC patients and 1,420 controls were genotyped for P53 codon 72Arg>Pro and MDM2 309T>G polymorphisms. Odds ratios (OR) and 95% confidence intervals (CI) of ESCC were estimated by logistic regression. We observed an increased risk of ESCC associated with the P53 Pro/Pro (OR, 1.83; 95% CI, 1.43-2.35; P < 0.001) or MDM2 GG (OR, 1.49; 95% CI, 1.16-1.91; P = 0.002) genotype, compared with the P53 Arg/Arg or MDM2 TT genotype, respectively. Interaction between these P53 and MDM2 polymorphisms increased risk of ESCC in a multiplicative manner, with the OR being 3.10 (95% CI, 2.07-4.69) for subjects carrying both P53 Pro/Pro and MDM2 GG genotypes. Significant interactions were observed between these polymorphisms and smoking, with risk being the highest (OR, 5.29; 95% CI, 2.91-9.61) in smokers having both P53 Pro/Pro and MDM2 GG genotypes. The MDM2 GG genotype was also associated with risk of developing poorly differentiated and advanced ESCC compared with the GT or TT genotype (OR for high-grade and stages III-IV versus low-grade and stages I-II = 1.60; 95% CI, 1.00-2.64; P = 0.049). The P53 and MDM2 polymorphisms may be genetic determinants for the development of ESCC.Keywords
This publication has 38 references indexed in Scilit:
- A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in HumansCell, 2004
- Genotoxicity of tobacco smoke and tobacco smoke condensate: a reviewMutation Research - Reviews in Mutation Research, 2004
- Functional Haplotypes in the Promoter of Matrix Metalloproteinase-2 Predict Risk of the Occurrence and Metastasis of Esophageal CancerCancer Research, 2004
- p53 Codon 72 Polymorphism and Cervical NeoplasiaCancer Epidemiology, Biomarkers & Prevention, 2004
- Time trends in cancer mortality in China: 1987–1999International Journal of Cancer, 2003
- The p53–Mdm2 module and the ubiquitin systemSeminars in Cancer Biology, 2003
- p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus‐associated carcinomas in ChinaCancer, 2002
- Assessing TP53 status in human tumours to evaluate clinical outcomeNature Reviews Cancer, 2001
- Risk factors for oesophageal cancer in northeast ChinaInternational Journal of Cancer, 1994
- Estimates of the worldwide incidence of eighteen major cancers in 1985International Journal of Cancer, 1993